MedCap
  • Home
  • About MedCap
    • About MedCap
    • Mission and Objectives
    • Investment Strategy
    • MedCap as an Owner
    • Board of Directors
    • Management
  • Operations
    • Operations
    • MedTech Business Area
    • Specialty Pharma Business Area
    • Market
    • Acquisition History
  • Investors
    • Investors
    • MedCap as an Investment
    • The Share
      • Share Data
      • Changes in Share Capital
      • Shareholder Structure
      • Insider Trading
      • Analysts and Market Makers
      • Dividend Policy
    • Financial Information
      • Interim Reports
      • Prospectus
      • Annual Reports
      • Presentations
      • Financial Targets
      • Investor Policy
      • IR Calendar
      • IR Contacts
      • Definitions
      • Accounting Policies
      • Key Figures
    • Corporate Governance
      • Corporate Governance Report
      • Articles of Association
      • General Meeting
      • Nomination Committee
      • Board Duties
      • Committees
      • Board Remuneration
      • Internal Controls
      • Management Duties
      • Remuneration
      • Auditors
    • Calendar
  • Sustainability
  • GDPR
  • Media
    • Media
    • Press Releases
      • Regulatory Press Releases
      • None-Regulatory Press Releases
    • Request Information
    • Image Archive
  • Contact
  • Search

Management remuneration

Guidelines for remuneration to the CEO and other senior executives

Guidelines for remuneration to the CEO and other senior executives are adopted by the annual general meeting. The annual general meeting of 13 May 2019 resolved that remuneration to the CEO and other senior executives shall comprise basic salary, variable remuneration, pensions and other remuneration. All pension benefits are defined contribution plans. Variable remuneration is prepared and approved by the board.

The allocation between basic salary and, where applicable, variable remuneration shall be in proportion to the executive’s responsibilities and authorities. The variable remuneration paid to the chief executive officer is capped at a maximum of 30 percent of annual salary. For other senior executives, the variable remuneration is capped at 0–30 percent of annual salary. The variable remuneration for the chief executive officer and other senior executives is based on the outcome of a number of quantitative parameters against set targets. The quantitative parameters relate to the company’s share price development, performance of operational management and the focus issues for each financial year.

Remuneration to the CEO and other senior executives

Remuneration to the CEO and other senior executives comprises basic salary, variable remuneration, pensions and other remuneration. All pension benefits are defined contribution plans. Variable remuneration is prepared and approved by the board. The allocation between basic salary and, where applicable, variable remuneration shall be in proportion to the executive’s responsibilities and authorities. The variable remuneration paid to the chief executive officer is capped at a maximum of 30 percent of annual salary. For other senior executives, the variable remuneration is capped at 0–30 percent of annual salary. The variable remuneration for the chief executive officer and other senior executives is based on the outcome of a number of quantitative parameters against set targets. The quantitative parameters relate to the company’s share price development, performance of operational management and the focus issues for each financial year.

The chief executive officer, Karl Tobieson, has an employment contract with six months notice period. For the Company the notice period is 12 months. Following termination of employment there is a six-month non-competition clause under which the company will compensate Karl so that he receives the same salary he received at the end of employment. Other senior executives have a three-month notice period or such longer period required by law, without severance pay, or they are engaged through a consulting agreement which has a three-month notice period. The chief executive officer and other senior executives are otherwise not entitled to any compensation in connection with termination of their employment.

In 2018 total remuneration to the chief executive officer and senior executives amounted to SEK 6 224 thousand (see breakdown in the table above).

The table below presents an overview of remuneration to the CEO and other senior executives who were also engaged by the company during financial year 2018.

SEKk Director’s fee/basic salary
consulting fee (ex. VAT)
Defined-contribution pension costs Variable remuneration Total remuneration
Karl Tobieson, CEO 2 305 249 555 3 109
Other senior executives (two individuals) 2 353 318 444 3 115
Total senior executives 4 658 567 999 6 224
  • Investors
  • MedCap as an Investment
  • The Share
    • Share Data
    • Changes in Share Capital
    • Shareholder Structure
    • Insider Trading
    • Analysts and Market Makers
    • Dividend Policy
  • Financial Information
    • Interim Reports
    • Prospectus
    • Annual Reports
    • Presentations
    • Financial Targets
    • Investor Policy
    • IR Calendar
    • IR Contacts
    • Definitions
    • Accounting Policies
    • Key Figures
  • Corporate Governance
    • Corporate Governance Report
    • Articles of Association
    • General Meeting
    • Nomination Committee
    • Board Duties
    • Committees
    • Board Remuneration
    • Internal Controls
    • Management Duties
    • Remuneration
    • Auditors
  • Calendar
  • About MedCap
  • Mission and Objectives
  • Investment Strategy
  • MedCap as an Owner
  • Board of Directors
  • Management
  • Operations
  • MedTech Business Area
  • Specialty Pharma Business Area
  • Market
  • Acquisition History
  • Investors
  • Investors
  • The Share
  • Financial Information
  • Corporate Governance
  • Calendar
  • Media
  • Press Releases
  • Request Information
  • Image Archive
  • Contact
MedCap AB | Sundbybergsvägen 1 | 171 73 Solna | +46 8 34 71 10 | info@medcap.se
Scroll to top